SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Paratek Pharmaceuticals Q1 EPS $(0.66) Beats $(0.80) Estimate, Sales $7.920M Beat $7.460M Estimate

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.660) per share which beat the analyst consensus estimate of $(0.800) by 17.5 percent. This is a 40 percent increase over losses of $(1.100) per share

Benzinga · 05/11/2020 10:50

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly losses of $(0.660) per share which beat the analyst consensus estimate of $(0.800) by 17.5 percent. This is a 40 percent increase over losses of $(1.100) per share from the same period last year. The company reported quarterly sales of $7.920 million which beat the analyst consensus estimate of $7.460 million by 6.17 percent. This is a 395.62 percent increase over sales of $1.598 million the same period last year.